TickerFacts.

TransMedics Group, Inc. (TMDX): Cost of Revenue

Annual figures by period end, from SEC filings.

$242.69M
Year ended 2025-12-31
$276.12M
Trailing 12 months to 2026-06-30
+105.0%
3-year compound annual growth
+93.3%
5-year compound annual growth
2018-12-29: $7.28M2019-12-28: $9.74M2020-12-31: $9.00M2021-12-31: $9.10M2022-12-31: $28.19M2023-12-31: $87.53M2024-12-31: $179.46M2025-12-31: $242.69M$242.69M
2018-12-29 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$242.69M+35.2%2026-02-24, From 2025-01-01
2024-12-31$179.46M+105.0%2026-02-24, From 2024-01-01
2023-12-31$87.53M+210.5%2026-02-24, From 2023-01-01
2022-12-31$28.19M+209.6%2025-02-27, From 2022-01-01
2021-12-31$9.10M+1.1%2024-02-27, From 2021-01-01
2020-12-31$9.00M-7.6%2023-02-27, From 2019-12-29
2019-12-28$9.74M+33.7%2021-03-11, From 2018-12-30
2018-12-29$7.28Mn/a2020-03-17, From 2017-12-31

Cost of Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
TransMedics Group, Inc. (TMDX)2025-12-31$242.69M+35.2%
InMode Ltd. (INMD)2025-12-31$79.53M+2.3%
Conmed Corp (CNMD)2025-12-31$624.25M+8.8%
LivaNova PLC (LIVN)2025-12-31$448.18M+12.1%
Axogen, Inc. (AXGN)2025-12-31$57.85M+27.5%
Integer Holdings Corp (ITGR)2025-12-31$1.35B+7.6%
Outset Medical, Inc. (OM)2025-12-31$72.72M-3.2%
Biolife Solutions Inc (BLFS)2025-12-31$34.10M+38.9%
Vaso Corp (VASO)2025-12-31$34.42M-0.8%

Compare TMDX, INMD, CNMD, LIVN side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗